Company: SONM
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001493152-25-020310
Chunk: 23

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Item 8
Chunk 23
---
 the Company’s
capitalization. The warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the investor
subsequent to the exercise exceeds the specified beneficial ownership limitation provided therein (which is currently 9.99% and may be
adjusted upon advance notice). On August 7, 2025, the Company and the investor entered into an amendment to reduce the exercise price
of the warrants to $13.50 per share.

On
May 12, 2025, the Company closed on a capital investment of 61,111 shares of common stock, as adjusted for the Reverse Stock Splits,
and 30,555 warrants, as adjusted for the Reverse Stock Splits, with two investors for an aggregate purchase price of $1,375. In connection
with the closing, the Company incurred approximately $169 in issuance costs, which was offset against the proceeds.

Each
warrant has an exercise price of $24.9552 per share, as adjusted for the Reverse Stock Splits, is immediately exercisable, will expire
in five years from the date of issuance, and is subject to customary adjustments for certain transactions affecting the Company’s
capitalization. The warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the investor
subsequent to the exercise exceeds the specified beneficial ownership limitation provided therein (which is currently 9.99% and 4.99%
and may be adjusted upon advance notice). On August 7, 2025, the Company and the investors entered into an amendment to reduce the exercise
price of the warrants to $13.50 per share, as adjusted for the Reverse Stock Splits.

In
connection with the close of the capital investment on May 12, 2025, the Company issued 1,375 warrants, as adjusted for the Reverse Stock
Splits, to Roth on July 2, 2025. Each warrant has an exercise price of $24.912 per share, as adjusted for the Reverse Stock Splits, is
immediately exercisable, will expire in five years from the date of issuance, and is subject to customary adjustments for certain transactions
affecting the Company’s capitalization. The warrants may not be exercised if the aggregate number of shares of common stock beneficially
owned by the investor subsequent to the exercise exceeds the specified beneficial ownership limitation provided therein (which is currently
4.99% and may be adjusted upon advance notice).

    16

AT